| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 06/19/2007 | CA2357256C Process for the integrated preparation of ammonia and urea |
| 06/14/2007 | WO2007066496A1 Benzoylurea compound and use thereof |
| 06/14/2007 | US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 06/14/2007 | US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 06/14/2007 | US20070135490 Phenetanolamine derivatives |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/13/2007 | CN1978426A Method for preparing disubstituted urea by carbon dioxide and amide reaction |
| 06/13/2007 | CN1321144C Low-cure powder coatings and methods for using the same |
| 06/12/2007 | US7230133 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis |
| 06/12/2007 | US7229981 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 06/07/2007 | WO2007064273A1 Phenyl urea derivatives |
| 06/07/2007 | US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors |
| 06/06/2007 | EP1792961A1 Low-cure powder coatings, related coating method and coated substrates |
| 06/05/2007 | US7226951 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| 05/31/2007 | WO2007062308A2 Homo- and heterocyclic compounds suitable as cetp inhibitors |
| 05/31/2007 | US20070123545 (1R,4S) or (1S,4R)-1-Amino-4-(hydroxymethyl)-2-cyclopentene D- or L-hydrogen tartrate intermediates |
| 05/31/2007 | US20070123512 Propionamide derivatives useful as androgen receptor modulators |
| 05/30/2007 | EP1789380A1 Amino adamantane derivatives, methods for the production and use thereof |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
| 05/29/2007 | US7223796 Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| 05/23/2007 | CN1968686A Guanylhydrazone salts, compositions, processes of making and methods of using |
| 05/23/2007 | CN1966491A Process for preparing disubstituted urea |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | US7220751 E.g., Cis-4-amino-cis-2-methyl-N-(6-methyl-2-(2-(2-pyridyl) ethenyl) quinazolin-4-yl)cyclohexylamine trihydrochloride; a nociceptin opiod-receptor agonist or antagonist effecting chronic pain and allodynia accompanied with herpes zoster |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007002635B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 05/17/2007 | US20070112070 2-Ethoxy-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]propanoic acid; cosmetics; dermatology; immunotherapy; lipid metabolism; skin disorders; antiinflammatory agents;antiallergens; antiproliferative agents; psoriasis; eczemia; respiratory systemdisorders; antiarthritic agents; anticarcinogenic agents |
| 05/16/2007 | EP1784387A1 Phenol compound, reversible thermosensitive recording medium, reversible thermosensitive recording label, reversible thermosensitive recording member, image-processing apparatus and image-processing method |
| 05/15/2007 | US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/10/2007 | WO2007013811A3 N-vanillyl urea derivatives as flavour modulating substances |
| 05/10/2007 | US20070106041 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution, used for separation of enantiomers, diastereomers of the template molecule, separation of template |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070104709 Non-naturally occurring ligand for umami taste and sweet taste receptor; enhancing response to artificial flavoring |
| 05/09/2007 | EP1781297A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2325741C Urea derivatives having tnf- .alpha. production inhibitory effects |
| 05/08/2007 | CA2176671C A material for elimination or detoxification of super antigens |
| 05/03/2007 | WO2007049656A1 Novel fluoroadamantane derivative and method for producing same |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007048557A1 Protease inhibitors |
| 05/03/2007 | WO2006122072A3 Processes for preparing biaryl ureas and analogs thereof |
| 05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | CA2625541A1 Ppar modulating biaromatic compounds |
| 05/02/2007 | EP1778628A1 Organic compounds |
| 05/02/2007 | EP1778626A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 05/02/2007 | EP1778214A2 Novel biphenyl compounds and their use |
| 05/02/2007 | EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1313443C Method for synthesizing sec-butyl urea |
| 05/02/2007 | CN1313439C Compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313072C Cosmetic compositions containing substituted amide derivatives |
| 04/26/2007 | WO2007046513A2 Benzoylurea compounds and use thereof |
| 04/26/2007 | WO2006128268A8 Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases |
| 04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
| 04/26/2007 | US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 04/25/2007 | EP1777246A2 Polymers containing amide groups for controlling rheology |
| 04/25/2007 | CN1951914A Process for synthesis of symmetrical aryl urea compound |
| 04/25/2007 | CN1951913A Process for the integrated production of urea and melamine |
| 04/24/2007 | US7208557 Functional monomers for molecular recognition and catalysis |
| 04/24/2007 | CA2289472C Excitatory amino acid receptor modulators |
| 04/24/2007 | CA2264135C Process for the preparation of urea |
| 04/19/2007 | US20070088083 2-[3-(2-Chloro-4-fluorobenzoyl)ureido]phenoxyacetic acid, used for the treatment of non-insulin dependent diabetes and for reducing blood glucose levels; antidiabetic agents |
| 04/18/2007 | EP1775284A1 Compounds comprising aldimine groups |
| 04/18/2007 | EP1773761A1 Histone deacetylase inhibitors |
| 04/18/2007 | CN1950335A Novel biaromatic compounds which activate PPAR.gamma.-type receptors, their process of preparation and their use in cosmetic or pharmaceutical compositions |
| 04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
| 04/17/2007 | CA2407759C Substituted phenylacetamides and their use as glucokinase activators |
| 04/17/2007 | CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 04/17/2007 | CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof |
| 04/17/2007 | CA2169873C Water dispersible polyisocyanate mixtures |
| 04/11/2007 | EP1073623B1 Substituted amino acids as erythropoietin mimetics |
| 04/11/2007 | CN1946682A Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester |
| 04/11/2007 | CN1946681A Method for producing polyether allophanates using zinc compounds as catalysts |
| 04/10/2007 | US7202269 GlyT2 modulators |
| 04/10/2007 | CA2195346C Benzocyclobutenones and polymers derived therefrom |
| 04/10/2007 | CA2165898C Process for the synthesis of urea comprising two separate reaction zones |
| 04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
| 04/05/2007 | WO2007036572A1 Compounds containing aldimine |
| 04/05/2007 | US20070078156 Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain |
| 04/05/2007 | CA2628324A1 Compounds containing aldimine |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/29/2007 | WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/28/2007 | EP1141147B1 Process for synthesis of allophanate compounds and compositions including the product thereof |
| 03/28/2007 | CN1307207C Incorporable photoinitiator |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307150C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/22/2007 | WO2006060774A3 Agents that inhibit flavivirus replication and uses thereof |
| 03/22/2007 | WO2006052542A3 Arylalkyl ureas as cb1 antagonists |
| 03/21/2007 | EP1763509A1 Alpha-helical mimetics |
| 03/21/2007 | EP1668086B1 Low-cure powder coatings and methods for using the same |
| 03/21/2007 | CN1931835A Process of extracting citrulline from water melon |
| 03/21/2007 | CN1305846C Novel urea derivatives |
| 03/21/2007 | CN1305839C Phenylglycine derivatives |